Machine Learning Empowered Breast Cancer Diagnosis: Insights from Coimbra Dataset Analysis

Aim: The aim of this work is to succinctly communicate the key aspects of a research study on breast cancer. This includes highlighting the global impact and prevalence of breast cancer, emphasizing the challenges of early diagnosis, discussing the potential of technological advancements, and showcasing the role of machine learning algorithms in the context of liver cancer diagnosis. Background: Cancer, notably breast cancer, represents a global health challenge, claiming a significant toll with 12.5% of new cancer cases annually. The prevalence of breast cancer among women worldwide is alarming, resulting in 2.26 million incidents and the unfortunate loss of 685,000 lives. Objective: This article focuses on the critical aspect of early breast cancer diagnosis, acknowledging its heightened difficulty in developing nations compared to developed counterparts. The potential for advancements in technology to serve as a beacon of hope lies in early identification and timely treatment, offering salvation to numerous women and significantly elevating survival chances. Method: In this intricate landscape, machine learning algorithms, particularly in diagnosing liver cancer at its nascent stages, emerge as instrumental tools. The study employs the latest Coimbra dataset, encompassing nine key attributes and a binary classification attribute, with values 1 and 2 signifying benign and malignant cases, respectively. Result: Supervised machine learning algorithms, including Bayes net, multilayer perceptron, IBK, random committee, and random tree, are meticulously applied. Certain models exhibit superior accuracy, precision, recall, and performance, positioning them as promising cornerstones for breast cancer analysis. Conclusion: This structured abstract highlights the urgent need for effective screening and prevention strategies, emphasizing the potential of advanced technology and machine learning algorithms to play a pivotal role in the early detection and analysis of breast cancer, offering hope for improved outcomes and survival rates.